Application 216109

Type
NDA
Sponsor
HIKMA PHARMACEUTICALS USA, INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ANCEFCEFAZOLININJECTABLE;INJECTIONEQ 2GM/VIALNoNo
002ANCEFCEFAZOLININJECTABLE;INJECTIONEQ 3GM/VIALNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N216109-001CEFAZOLIN SODIUMCEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07
N216109-002CEFAZOLIN SODIUMCEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 50 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07011fe1cb6892…
2026-02-19 14:30 UTC2026-02N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-0731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-0731067a03dcf5…
2025-08-23 18:47 UTC2025-08N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-076a471c1ec25d…
2025-08-23 18:47 UTC2025-08N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-076a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-0703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-0703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-072680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-072680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-075bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-075bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07d06236e962d9…
2024-10-29 15:01 UTC2024-10N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-0779d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-0779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-071e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-071e350fbaab3a…
2024-05-31 18:47 UTC2024-05N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-078072bd15b7f6…
2024-05-31 18:47 UTC2024-05N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-078072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-076a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-076a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-071c564ffb4f44…
2024-02-18 07:12 UTC2024-02N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-071c564ffb4f44…
2023-12-20 04:57 UTC2023-12N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-079b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-079b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N216109-001CEFAZOLIN SODIUMEQ 2GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N216109-002CEFAZOLIN SODIUMEQ 3GM BASE/VIALPOWDER / INTRAVENOUSRLD, RS2022-10-07a67488948f0b…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CefazolinCEFAZOLINHikma Pharmaceuticals USA Inc.6c7761d3-c154-4802-9876-627cd42913f02024-12-31Warnings, Adverse reactionsExact identifier
application applno (NDA): 216109
application number: NDA216109

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
80644SUPPL 2024-12-19
80638SUPPL 2024-12-19
74642ORIG 2023-06-28
72297ORIG2022-10-11
72292ORIG2022-10-11